RE: Valuation – Polygon’s Original Expectations?18 Apr 2023 18:12
"I don't think their strategy has changed. Mid to long term investment. Wait. Let the science and data accumulate until an inflection point gives them an exit on the back of some attractive commercial deal that satisfies their price target. "
I think that’s different from their original strategy, which (like for many of us) was to buy in advance of positive trial results and then sell at a mahoosive profit.
I would guess their subsequent strategy has been to look gloomily at the valuation on their books while having many meetings to discuss what to do with this lame duck investment, and hoping that Synairgen somehow find a way out of this mess.